Plandai Biotechnology, Inc. Provides Year-End Shareholder Update
December 31, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
LOGAN, UT--(Marketwired - December 31, 2014) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a developer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical,...
Uruguay's Presidential Election Favors Plandai Biotechnology's Future Cannabis Research
December 04, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - December 04, 2014) - Timing is everything and when Plandaí Biotechnology (OTCQB: PLPL) was given the go-ahead to grow cannabis for medical research in Uruguay, little did...
Plandai Biotechnology Could Offer Potential Anti-Viral Protection With Phytofare(TM) Catechin Complex Entrapped in Pheroid(R)
November 18, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - November 18, 2014) - Plandaí Biotechnology (OTCQB: PLPL) entered into an agreement late last year with North West University in South Africa, that will allow it to use the...
Plandai Biotechnology Collaboration Offers Opportunity to Produce a Non-Psychoactive Cannabis Product for Medical Research
November 10, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - November 10, 2014) - Plandaí Biotechnology (OTCQB: PLPL) has entered into a collaboration agreement in Uruguay that will give the company the potential to produce a...
Plandai Biotechnology, Inc. Receives Approval to Grow Cannabis for Medical Research From Uruguay's Ministry of Public Health
October 29, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - October 29, 2014) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) ("Plandaí" or "the Company"), a developer of highly bioavailable plant extracts for industries including...
FDA Exemption Has Plandai Biotechnology Heading Into Third Quarter Ready to Commence Sales of First Phytofare(TM) Product
June 26, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Jun 26, 2014) - Plandaí Biotechnology (OTCQB: PLPL) recently learned that it qualifies for an exemption that will allow the company to commence sales of its...
Plandai Biotechnology up for $2.5 Million Grant in Continued Support From South African Government
May 02, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - May 2, 2014) - Plandaí Biotechnology (OTCQB: PLPL) could soon receive another injection of money from the South African government, and this time it's in the form...
Plandai Biotechnology Recruiting Now for Human Clinical Trials to Begin in May
April 30, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Apr 30, 2014) - Plandaí Biotechnology (OTCQB: PLPL) has been given the go-ahead to conduct human clinical trials in a 3-month study that will compare the oral...
Plandai Biotechnology Closer to Unzipping the Magic of Phytofare in New Facility
April 04, 2014 08:30 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Apr 4, 2014) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) welcomes the month of April with a brand new state of the art production facility that is due to be fully...
Plandai Biotechnology's Human Clinical Trials Offer Significant Proof of Concept
March 26, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Mar 26, 2014) - What may have been lost in Plandaí Biotechnology's (OTCQB: PLPL) recently reported results from its human clinical trial to test the anti-aging...